The alternatives
SnagRx scores 68/100 (grade C, ranked #153) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to SnagRx's 68, and our SnagRx vs CoreAge Rx comparison sets the two out factor by factor.
Sells compounded semaglutide and tirzepatide as a weekly shot or a daily tablet, with first-month prices on its home page — but no public page prints what month two costs.
SkinnyRx matches SnagRx at 68/100; our SkinnyRx review in full has the pricing conditions and the caveats in detail.
Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.
Willow matches SnagRx at 68/100; our full write-up on Willow has the pricing conditions and the caveats in detail.
A six-shelf prescription telehealth catalog advertising compounded GLP-1s from $171 to $240 a month — but no page says which plan length those prices need, and the full price list stays hidden until you give a mobile number.
MyDrHank matches SnagRx at 68/100; the full MyDrHank review has the pricing conditions and the caveats in detail.
Names its six dispensing pharmacies and two of its prescribing physicians with NPIs you can check — and sells no month-to-month plan at all, so the advertised “$199/mo average” is $597 charged every twelve weeks.
Pallas Health scores 70/100 to SnagRx's 68; our full write-up on Pallas Health has the pricing conditions and the caveats in detail.
One price at every dose and no membership fee — but Oak publishes nine different "starting" prices, attaches a billing term to none of them, and will not name a rate until you have finished a 29-question intake.
Oak matches SnagRx at 68/100; our full write-up on Oak has the pricing conditions and the caveats in detail.
A clean product page with a published price, in front of intake funnels that quote different numbers and sell a different program.
Andrew Meds scores 70/100 to SnagRx's 68; our full write-up on Andrew Meds has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.